PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple myeloma |
| Phenotype | C0031117|peripheral neuropathy |
| Sentences | 11 |
| PubMedID- 22297012 | Bortezomib-induced peripheral neuropathy in patients with multiple myeloma. |
| PubMedID- 21654882 | Its marked safety and comparable efficacy in multiple myeloma patients with pre-existing peripheral neuropathy makes it a drug that will integrate well with other active agents. |
| PubMedID- 20467223 | [severe bortezomib-induced peripheral neuropathy in a patient with multiple myeloma]. |
| PubMedID- 22110934 | peripheral neuropathy in patients with multiple myeloma occurs as both disease- and treatment-related complication in the relapsed and newly diagnosed setting. |
| PubMedID- 25154818 | Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. |
| PubMedID- 21749306 | Prevalence of peripheral neuropathy in multiple myeloma at initial diagnosis. |
| PubMedID- 24867959 | A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. |
| PubMedID- 23372151 | peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (rvd) therapy. |
| PubMedID- 22193964 | Management of treatment-emergent peripheral neuropathy in multiple myeloma. |
| PubMedID- 20932799 | Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. |
| PubMedID- 25399783 | Therapy-related peripheral neuropathy in multiple myeloma patients. |
Page: 1